Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3Jinnan Yue, Lu Xu|Oncogene|2018Cited by 111
Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLCLing Li, Lu Xu|Oncotarget|2017Cited by 34
Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC)Qingnan Zhao, Lu Xu|Oncotarget|2015Cited by 32